Neuropharmacology and Neurodegenerative Diseases

Neuropharmacology is employed to review the characteristics of drug interaction with the cells present within the brain. The drug interaction with the cell within the two forms, Behavioural and Molecular. Behavioural neuropharmacology is employed to review the drug function within the brain and find how it changes the human behaviour.

Molecular pharmacology involves the study of neurons within the brain and finds the neurochemical interaction between each neuron.

Neurodegenerative disease  is that the progressive degeneration of the central systema nervosum and peripheral systema nervosum . This gradual deterioration ends the function and structure of the brain. The widespread of  neurodegenerative diseases are Alzheimer’s diseases, Parkinson’s diseases. Neurodegenerative diseases are untreatable conditions that end in gradual degeneration of nerve cells. Spinal muscular atrophy may be a sort of neurodegenerative diseases. Multiple sclerosis is that the disease during which the system eats the outer most covering of the nerve cells. during this case the treatment can prolong the life, it can't be cured. The symptoms of MS are vision loss, fatigue, pain, and impaired coordination.

  • Track 1-1 Behavioural neuropharmacology
  • Track 2-2 Molecular pharmacology
  • Track 3-3 Amyotrophic lateral sclerosis
  • Track 4-4 Aneurysm
  • Track 5-5 Multiple sclerosis
  • Track 6-6 Spinal cord injury
  • Track 7-7 Spinal muscular atrophy

Related Conference of Neuroscience